Helius Medical Technologies, a company listed on Nasdaq, has announced plans to build a $500 million reserve of Solana
To support this plan, Helius completed a private stock sale, which offered shares at $6.88 each. Investors also received warrants, contracts that allow them to purchase additional shares for $10.12 over the next three years.
In total, the equity funding adds up to $500 million, with the potential for $750 million more if all warrants are used.
Did you know?
Subscribe – We publish new crypto explainer videos every week!
How to Pick the Right DeFi dApp? (Dos and Don’ts Explained)
The funds will be used to buy and manage Solana tokens over the next year or two. The company plans to grow its holdings and uses a mix of public market tools, including stock sales and other established methods.
It will also explore ways to earn extra income through activities such as staking and lending Solana, while maintaining a cautious approach to risk.
Dan Morehead of Pantera Capital said that Helius’s initiative could help more people and institutions gain access to the Solana network.
As part of this transition, Joseph Chee will step in as executive chairman of Helius. He currently leads Summer Capital and formerly headed investment banking in Asia for UBS.
The investment round is led by Pantera Capital, a US-based cryptocurrency investment firm, and Summer Capital, an Asian asset manager. Other backers include Avenir, Big Brain Holdings, FalconX, Arrington Capital, Animoca Brands, and HashKey Capital.
Recently, Amdax, a digital asset company based in the Netherlands, announced plans to launch AMBTS B.V. on the Amsterdam Stock Exchange. What is it? Read the full story.
